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nervous system, adenocarcinoma, hepatocarcinoma, cer-
vix squamous carcinoma, and ovarian cancer cell lines, 
at micromolar alkylresorcinols concentration. Evidence 
from prospective studies confirmed significant inverse 
associations between whole grains intake and distal 
colon cancer risk. Model studies suggest a high cyto-
toxicity of alkylresorcinols toward cancer cells. These 
findings maintain that alkylresorcinols as components 
of whole grains are likely to find application in cancer 
prevention; however, the need for intervention studies to 
confirm their preventive action is warranted.
Keywords Alkylresorcinols · Bioactivity · Cancer · 
Prevention · Cytotoxicity
Abbreviations
ARs  Alkylresorcinols
ROS  Reactive oxygen species
IGF  Insulin growth factor
LDL  Low-density lipoprotein
ROO·  Peroxyl radical
FFQ  Food frequency questionnaire
IC50  Inhibitory concentration–inhibit cellular prolifera-
tion by 50%
PSA  Prostate specific antigen
OR  Odds ratio
IRR  Incidence rate ratio
CI  Confidence interval
TGI  Concentration of drugs that totally inhibit cell 
growth
LC50  Concentration of drugs resulting in cell death to 
50%
5-AR  5-Alkylresorcinol
DNA  Deoxyribonucleic acid
ATP  Adenosine triphosphate
Abstract The potential role of alkylresorcinol com-
pound from whole grains for prevention and inhibition 
of human cancer cell lines has been reported in obser-
vational and in vitro studies. The objective of this study 
was to present an updated review on the association 
between alkylresorcinols and cancer risk and aspects of 
their bioactivity with implications for carcinogenesis. 
Relevant studies were identified by searching PubMed, 
Scopus, ProQuest, EBSCOhost, SpringerLink, Arti-
cleFirst, Taylor & Francis, Wiley Online, and Science-
Direct electronic databases using these search terms and 
key words: alkylresorcinols, cancer, carcinoma, risk. 
Furthermore, references from retrieved articles were 
also reviewed. Four observational and 10 in vitro stud-
ies were included in the analysis of natural or synthetic 
alkylresorcinols for anticancer activities. Two prospec-
tive studies reported a 52–66% risk reduction of distal 
colon cancer at nanomolar alkylresorcinols concentra-
tion in plasma; the remaining studies found no reduc-
tion of endometrial cancer risk and an approximate 40% 
increase in prostate cancer risk. In vitro studies pre-
sented inhibition of human colon, breast, lung, central 
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Introduction
There are several environmental factors that influence 
cancer development. Studies demonstrate an independ-
ent effect of dietary patterns on cancer risk which are 
modifiable by diet. Evidence suggests that diet represents 
30–35% of all risk factors contributing to the onset of 
cancer. Positive health effects have been reported for veg-
etables, fruits, and whole grains [1–6]. Whole grain foods, 
rich in dietary fiber, minerals, vitamins, and phytochemi-
cals, are recognized as agents exerting health protective 
effects [7]. Much of the research on relationships between 
diet and cancer risk is based on the hypothesis that high 
intake of these nutrients rich in antioxidants (e.g., polyphe-
nolic compounds, lignans, vitamins) may affect a number 
of physiological and pathological processes, like signaling 
mediated by MAP-kinases, insulin growth factor (IGF-1), 
nuclear transcription factor (NF-κβ), cytochrome P450, and 
reactive oxygen species (ROS) [8, 9]. Transformation of 
healthy cells and tumorigenesis can be linked to increased 
DNA mutagenesis, decreased apoptosis, increased cell pro-
liferation, inflammation, and several other processes con-
trolled by antioxidants, thus antioxidants can prevent DNA 
damage and potentially protect against cancer [10–13]. 
Nonetheless, the scientific evidence on diet–cancer risk 
interactions is not conclusive [5, 14]. Over the last two 
decades, research interest in medicine and functional food 
production in the application of whole grains and dietary 
phytoestrogens has increased significantly [1, 15]. Of par-
ticular interest in relation to tumorigenesis is the class of 
natural compounds, like phenolic lipids also known as 
alkylresorcinols (ARs) (Fig. 1).
A wide range of biological properties of ARs, includ-
ing antimicrobial [16], antimutagenic [17], and antioxi-
dant potency have been reported [7, 18]. Epidemiologic 
evidence demonstrates that consumption of whole grain 
cereals is associated with positive health benefits such as 
decreased risk of overweight and obesity, coronary heart 
disease, diabetes, and some types of cancer [19–24]. There 
is insufficient evidence to support the association of ARs 
with decreased risk of cancer because whole grains beside 
phenolic lipids contain a high number of primary metab-
olites (e.g., fiber, sulfur amino acids, lignin, oligosaccha-
rides, minerals, vitamins), polyphenols (e.g., phenolic 
acids, flavonoids, lignans), phytosterols, melatonin, and 
other bioactive compounds [7, 15, 21, 25]. In addition, 
each of these compounds exhibits biological actions which 
are frequently reported in the literature as health protec-
tive mechanisms. In view of these facts, the main objective 
of this review article is to evaluate and present the current 
Fig. 1  General structure and 
common dietary sources of 
alkylresorcinols (R = n-alkyl or 
n-alkenyl chain)
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evidence related to ARs and cancer risk and some aspects 
of the AR’s biological activities related to carcinogenesis. 
Occurrence, pharmacokinetics, extraction, and analysis of 
ARs will be also presented briefly.
Methods
An integrative review of the literature was carried out 
prior to January 2017. Relevant articles were identified 
by applying search strategies to nine academic elec-
tronic databases: PubMed, Scopus, ProQuest, EBSCO-
host, SpringerLink, ArticleFirst, Taylor & Francis, 
Wiley Online, and ScienceDirect. Search terms and key 
words included: Alkylresorcinols; cancer; carcinoma; 
risk. These databases were chosen due to their extensive 
coverage of biomedical and cross-disciplinary research 
objectives and scope. All retrieved titles, abstracts, and 
full-text publications were reviewed and screened for 
relevance to the topic. Furthermore, references from 
retrieved articles were reviewed to identify additional 
applicable publications.
Inclusion/exclusion criteria
Inclusion criteria for refereed study samples included 
observational and in vitro studies. Other article types 
such as conference abstracts, communications, commen-
taries, editorials, brief reports, position, and hypothesis-
generating statements were excluded. Gray literature and 
non-refereed publications were also excluded. No lan-
guage restrictions were imposed. A flowchart of the study 
screening and selection is presented in Fig. 2.
Fig. 2  Flow diagram of litera-
ture search process 538 total citations identified from database search results-
PubMed: 22
Scopus: 24
ScienceDirect: 204
EBSCOhost: 173
SpringerLink: 26
Taylor & Francis Online: 17
Wiley Online: 37
ArticleFirst: 3
ProQuest: 32
404 citations excluded after 
abstract screening and 
duplicates removed (n=134) 
Eligible citations passed full-
text screening and inclusion 
criteria (n=26)
PubMed: 2
Scopus: 19
ScienceDirect: 4
Wiley Online: 1
2 citations added after 
checking reference lists
110 citations excluded after
full -text screening for 
relevance (n=24)
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Results
Prevalence of alkylresorcinols
This large group of phenolic compounds (1,3-dihy-
droxy-5-n-alkylbenzenes) (about 150 natural occurring 
ARs) [26] consists of a single phenolic ring with two 
hydroxyl groups (OH) in the meta-position and odd num-
bered alkyl side chain (R) which can contain between 
13 and 27 carbon atoms with dominance in the range 
of C15–C25 at position 5C in the benzene ring [27]. 
The hydrocarbon chains can contain two double bonds 
between carbon atoms, ketone, or hydroxyl groups. The 
chemical structure and length of chains depend on bio-
logical origin [28]. The following five major classes of 
ARs have been reported in whole grain, wheat, and rye: 
5-n-alkylresorcinols, 5-alkenylresorcinols, 5-oxoalkylres-
orcinols, 5-oxoalkenylresorcinols, and 5-hydroxyalkenyl-
resorcinols [15]. Alkenylresorcinols, the phenolic lipids 
with unsaturated hydrocarbon side chains, accounted for 
about 20% of the total amount of ARs as were identified 
and quantified by Söderholm et al. in rye bread [29].
These compounds are present in several plant fami-
lies and some bacteria, fungi, algae, and marine sponges 
[27]. Among food plants, ARs occur in the whole grain 
or bran fractions; they are distributed in the outer cutic-
ula of the testa and inner cuticula of the pericarp in rye, 
wheat grains, and in smaller amounts in barley. Various 
cereal grains are grown in different countries, depend-
ing on climatic conditions. In the regions with cold tem-
perature and poor quality soils, rye is an important cereal 
grain, although cultivation of rye constitutes just 3% of 
the worlds wheat production. The AR content, its chemi-
cal structure, and the homologue ratios differ between 
cereal grains and are dependent on several environmental 
factors like geographical region, soil composition, fertili-
zation, and cultivation [30–32]. ARs occur mainly in the 
outer parts of whole wheat and rye products at high con-
centrations (200–4000 µg per gram of dry matter) and at 
low concentration in refined flour or products (40–280 µg 
per gram of dry matter) [33–35]. ARs are proposed as 
valid biomarkers of whole grain and rye consumption of 
cereal grains which are the main human food crop [30, 
36–39]. The ARs concentration is dependent on grain 
type. For example, rye contains about 797–1231 µg/g of 
dry matter, wheat 220–650 µg/g of dry matter, and bar-
ley 40–110 µg/g of dry matter [40]. A relative high con-
centration (489–1429 µg/g of dry matter) of ARs occurs 
in wheat bran [15] of which human consumption has 
increased over the years [41]. Among cereal grains such 
as rye, wheat, and durum wheat, rye is richest in ARs 
[42].
Alkylresorcinols during grain processing
In contrast to whole grain foods, refined products contain 
only trace-concentrations of AR [15]. Grain processing 
(e.g., milling, cooking, fermentation) changes the nutri-
tional content of cereal grains by fragmentation of the grain 
matrix and gelatinization of starch granules [7, 43]. Due to 
occurrence of ARs, vitamins, minerals and trace elements, 
and antioxidants in the outer parts of the grain, the final 
nutrient content will be dependent on the extent to which 
the outer parts are removed during processing. For exam-
ple, refining whole grain wheat may result in the loss of 
about 58% of fiber, 79% of zinc, 79% of vitamin E, 83% 
of magnesium, and 92% of selenium [7]. High-temperature 
processing of cereal grains decreases AR content in grain 
food due to denaturation and degradation [15].
Anti‑nutrients in grain cereals
Notably, whole grain cereals also contain anti-nutrients 
which exert both adverse and positive health effects [7, 
44–46]. Anti-nutritional factors can reduce nutrient intake, 
design, absorption, and utilization. The factors are natu-
rally present in grains or they originate from contamination 
(fungal origin, related to soil and other environmental influ-
ences). The most important are phytic acid, lectins, tan-
nins, saponins, inhibitors of proteases, and amylases which 
modify the nutritional values of cereals. For example, tan-
nins and the phosphorus compound phytic acid can bind 
iron, calcium, and zinc; lectins can damage the intestinal 
microvilli and interact with antibodies, thus stimulating an 
immune system response. There is significant interest in 
understanding how processing influences concentrations of 
bioactive phytochemicals present in whole rye, wheat, and 
barley from different cultivations and in obtaining func-
tional ingredients rich in ARs [34, 47]. Therefore, several 
reduction strategies have been developed to reduce anti-
nutrients and improve whole grain foods. For example, 
processing of cereal grains through cooking, roasting, fer-
mentation, and germination may decrease concentration of 
tannins and phytic acid [3, 7].
Pharmacokinetics of alkylresorcinols
According to a scheme proposed by Landberg et al. [48], 
presenting the pathways of AR absorption, distribution, 
metabolism, and excretion, the compounds are absorbed 
in the small intestine, although there is no clear evidence 
describing the mechanism of absorption. The authors sug-
gested that in the intestinal cells ARs can be assembled 
into chylomicrons, followed by their transportation into the 
lymphatic system. The compounds may also be absorbed 
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directly during transfer to HDL (high-density lipopro-
tein), LDL (low-density lipoprotein), and VLDL (very 
low-density lipoprotein) fractions. Next, from lipoproteins 
ARs are distributed into erythrocyte membranes, wherein 
the plasma-erythrocyte ratio is dependent on the chain 
length ranging from 0.5 to 1.3, being higher for longer 
homologues. An analysis of AR level in erythrocytes and 
in plasma showed that their concentration was maximal 
after about 13 h post-feeding (300–500 nM) and at 7 h 
(3365 nM), respectively when ARs are consumed several 
times daily. The ARs absorption level and elimination half-
time, the time at which the excretion rate decreases to half 
of the maximal excretion rate in humans and animals, are 
the individual features changing at different value ranges 
between individuals [26]. Similar to tocopherols, ARs are 
eliminated from circulation with an apparent half-life about 
of 5 h [48]. These findings, as well as studies on metabo-
lism of resorcinols and 4-n-nonylphenyl, propose similar 
metabolism of ARs as tocopherols including two phases. 
In phase I, ARs are metabolized by the introduction of a 
hydroxyl group (HO) at the end of the alkyl tail through 
omega-oxidation catalyzed by cytochrome P450 isoenzyme 
CYP4F2. Next, the HO group is oxidized to a carboxylic 
acid, followed by successive β-oxidation, thus making the 
alkyl chain shorted, and two main water-soluble metabo-
lites: 3-(3,5-dihydroxyphenyl)-1-propanoic acid (DHPPA) 
and 3,5-dihydroxybenzoic acid (DHBA) are final products 
of this phase [42–48]. In phase II, ARs and their interme-
diate and final metabolites are partially conjugated by a 
polar group to xenobiotics or endogenous compounds. 
Conjugation with glucuronide sulfate groups and amino 
acids is the key reaction improving urinary excretion of AR 
metabolites. Two AR metabolites DHPPA and DHBA were 
detected in plasma and human urine [29, 49, 50] and con-
sidered as biomarkers of whole grain wheat and rye intake. 
For example, Söderholm et al. observed maximum exer-
tion rates of 5–6 h for DHPPA and DHBA metabolites, and 
significant amounts were still measurable at 25 h in human 
urine [29]. Recently, new ARs metabolites 3,5-dihydroxy-
cinnamic acid (DHCA), 5-(3,5-dihydroxyphenyl) penta-
noic acid (DHPPTA), 3,5-dihydroxycinnamic acid amide 
(DHCA-amide), and 2-(3,5-dihydroxybenzamido)acetatic 
acid (DHBA-glycine) were developed in human urine 
samples [51, 52]. Although their concentrations in urine 
were considerably lower than those of DHPA and DHPPA 
metabolites [52], they are suggested as potential biomark-
ers for whole grain wheat and rye intake [51, 52].
Extraction and analysis of alkylresorcinols
For analytical studies, ARs require previous extraction and 
identification. The extraction process from cereal grains is 
important for accurate quantification of AR content in whole 
grain food products as they are potentially phytochemicals 
for use in disease prevention. Several methods including 
modern technologies have been applied to the extraction 
of ARs from plant material, mainly conventional solvent 
extraction, ultrasonic-assisted extraction (UAE), and sub-
critical fluid extraction (SFE) [15]. Briefly, the conventional 
extraction methods include Soxhlet extraction, stirring, 
distillation, manual mixing, and percolation. The extrac-
tion methods use refluxing samples with different organic 
solvents like acetone, ethylacetate, hexane, and propanol-
water mixture (3:1) because ARs are insoluble or poorly 
soluble in water. Extraction methods are expensive and time 
consuming (1–48 h). SFE is a technique that uses a super-
critical fluid as the extracting solvent and carbon dioxide 
 (CO2) is the most used supercritical fluid [53, 54]. The fluid 
is allowed to flow at a desired pressure of 40 MPa through 
a milled sample at an extracting temperature of 40–80 °C. 
The  CO2 fluid is often modified using ethanol or methanol 
to increase the extraction yield. The major advantage of 
SFE-CO2 is high selectivity which shortens extraction time 
and lowers organic solvent costs compared to conventional 
extraction methods. Similarly, UAE is an efficient and inex-
pensive modern extraction technique of increased selec-
tivity and kinetics. In UAE extraction, ultrasound is used 
to break the cell membranes. Diffusion of solvent through 
membranes is accelerated, thus the release of cell contents is 
facilitated [55]. It is worth noting that an important property 
of compounds containing phenol group, like antioxidant 
potential, may be influenced by the extraction solvent and 
extraction time [56]. However, no qualitative or quantita-
tive differences in AR extradition were found after applying 
supercritical  CO2 and conventional extradition using ethyl 
acetate [57]. To determine the AR structure–activity rela-
tionship, synthetic compounds are prepared using Grignard 
and Wittig reactions [58]. Colorimetric methods, thin-layer 
chromatography, high-performance liquid chromatography, 
gas chromatography, mass spectrometry, and nuclear mag-
netic resonance are the techniques used for ARs separation, 
identification, structure establishment, and qualitative and 
quantitative analysis [15, 54, 59].
Biological activity of alkylresorcinols
ARs exhibit a wide range of biological properties due to 
their amphiphilic properties resulting from the presence of 
polar water-soluble OH groups attached to the benzene ring 
and the presence of a water-insoluble hydrocarbon chain. 
Current evidence for the biological importance of ARs is 
based mainly on in vitro examination. Three kinds of posi-
tive effects of whole grain cereals are identified: nutritional, 
mechanistic (due mainly to the fiber content), and antioxi-
dant (due to ARs and phenolic acids) [39, 60].
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Detections of ARs or their main metabolite concentra-
tion in blood plasma, erythrocytes, adipose tissue, and in 
urine are used to estimate whole cereal intake. Several 
studies reported positive correlations between whole grain 
intake and the presence of ARs in plasma or their urinary 
metabolites [36, 51, 61–69]. Finding of in vitro studies 
have shown that ARs exhibit a broad range of bioactivities 
including a high affinity to liposome and erythrocyte mem-
branes increasing their permeability, antifungal, antimicro-
bial, and anticancer abilities [70–78]. ARs can potentially 
affect all processes regulated by enzymes; this suggests that 
ARs may exhibit anti-oxidative, anticancer, and antimuta-
genic activities, induction of apoptosis, and inhibition of 
some enzymes activities including lipoxygenases, mono-
amine oxidase, tyrosinase,  Ca2+-ATPase, α-glucosidase, 
dehydrogenase, DNA polymerase β, and lipase in the adi-
pose tissue cells. ARs may also reduce adipose triglycer-
ide, decrease copper-induced oxidation of LDL, inhibit 
DNA-strand scission, and limit nucleic and protein synthe-
sis in thymocytes [42, 71, 72]. In vitro experiments show 
an inhibition of the human 20S chymotrypsin producing 
proteasome activities by several synthetic ARs and their 
homologues with a high potency. This human proteasome 
includes the catalytic core of a proteinase complex playing 
several important functions in cells such as controlling pro-
teins p53, p27, and cyclin B levels and the ATP-dependent 
ubiquitin-mediated protein degradation [58].
Whole grains can improve insulin sensitivity due to 
their low glycaemic index [49]. Biskup et al. reported 
that only whole grain intake dominated by rye consump-
tion may be important for type 2 diabetes mellitus preven-
tion based on case-control study (931 cases, 931 controls) 
[65]. Ross et al. reported ARs can regulate with the high 
potency the γ-tocopherol and cholesterol concentrations 
in rat livers [79]. Further, the researchers found high doses 
of AR intake decreased excess hepatic lipids which can 
lead to hepatic insulin resistance and type 2 diabetes and 
increased concentrations of γ-tocopherol caused by slower 
metabolism [80]. In turn, a large population-based inter-
vention study reported whole grain consumption is linked 
with decreased concentration of non-esterified fatty acids 
in plasma [36]. Also, Söderholm et al. found decreased per-
oxidation of LDL in the presence of copper ions in humans 
after 4 weeks of rye bread consumption [81]. Considering 
the antioxidant potential of ARs, it is worth noting that this 
activity is estimated at 10% of α-tocopherol antioxidant 
capacity, and the hydrogen donation ability of ARs cor-
responds to 30% of that exhibited by ferulic acid [36, 42, 
82–85].
Some reports indicate weak direct antioxidant activi-
ties of ARs due to their hydrogen atom donor and free 
radical scavenging activities [60, 82, 83], but note a 
strong protective action in phospolipid bilayers, such 
as inhibition of linolenic acids oxidation and protection 
against  H2O2-induced oxidation of erythrocytes [42]. The 
weak direct antioxidant power of ARs using the ferric 
reducing ability of plasma and DPPH assays was observed 
by Parrika et al. [82] who reported antioxidant activities 
of several ARs with chains lengths C15:0, C17:0, C19:0, 
C21:0, and C23:0 using the HT29 human colon can-
cer cells. ARs were found to increase the self-protection 
properties of these cells against DNA damage caused by 
 H2O2 or genotoxic fecal water samples. Parrika et al. also 
observed a strong protective effect of these compounds 
against the Cu ion-induced oxidation of low-density lipids. 
Notably, lipid peroxidation is currently considered as the 
main biochemical mechanism involved in cell damage [13, 
86]. Peroxidation of lipids is a chain reaction with repeti-
tive H abstraction by hydroxyl radical and peroxyl radi-
cal. The main target is methylene group of polyunsaturated 
lipids. An addition of molecular oxygen  (O2) to the alkyl 
radicals resulting in generation of peroxyl radicals  (ROO·) 
leads to their oxidative destruction [86]. The antioxidant 
property of ARs as polyphenolic compounds originates 
from the ability of their hydroxyl groups to donate H to a 
free radical, or to donate one electron to an alkyl free radi-
cal, which breaks the chain reaction of lipid peroxidation. 
Thus, ARs may modulate cellular redox state and protect 
proteins, phospholipids, DNA, RNA, and carbohydrates 
against peroxidation [82, 84, 85, 87].
There are no oral dosing studies that examine pure ARs 
in humans [38]. Only a few dietary clinical intervention tri-
als have studied the effect of whole grains intake on health 
[20, 88–91]. For example, in a 12-week observational 
dietary intervention trial (n = 79), Kristensen et al. exam-
ined the effect of replacing refined wheat with whole grain 
wheat on body weight and percent body fat [90]. The out-
come suggested intake of whole grain products may cause 
a greater reduction in fat mass percentage but was not asso-
ciated with body weight change. Moreover, total and LDL 
cholesterol in serum was found to be increased in refined 
wheat consumers compared to whole grain wheat con-
sumers (5.91 vs. 5.59 nM, p = 0.02 and 3.96 vs. 3.73 nM, 
p = 0.02, respectively). In turn, Tighe et al. found that daily 
intake of three portions of whole grain foods reduced car-
diovascular disease in middle-aged people [89].
Prospective studies
Four observational studies [69, 92–94] were included in 
analysis of the association of ARs intake with cancer risk, 
among which two studies [92, 93] involved colorectal can-
cer. One study dealt with prostate cancer [69] and one study 
[94] with endometrial cancer (Table 1). The first study 
on colorectal cancer included a large, multicenter cohort 
with more than one million individuals from 10 European 
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countries [92]. Total plasma concentration defined as a sum 
of plasma AR homologues C17:0, C19:0, C21:0, C23:0, 
and C25:0 was analyzed in matched case-control pairs. 
The incidence rate ratio (IRR) of distal colon cancer was 
reduced by 52% among individuals with AR concentrations 
in plasma >99 nM in men and >84 nM in women (78 cases, 
114 controls). Also, a 17% reduction in IRR of colon can-
cer was reported for Scandinavian participants (252 case-
control pairs). The investigators noticed an inverse relation-
ship between total plasma AR concentrations and colon and 
distal colon cancer which occurred only in individuals from 
areas where intake of ARs is high, stable, and frequent, i.e., 
in the Central Europe and Scandinavia.
The second study on the AR-colorectal cancer relation-
ship examined levels of plasma AR homologues (C17:0, 
C19:0, C21:0, C23:0, and C25:0) and also used the food 
frequency questionnaire (FFQ) of whole grain intake [93]. 
The study included three cohorts: The Norwegian Women 
and Cancer Study, the Northern Sweden Health and Dis-
ease Study, and the Danish Diet, Cancer, and Health Study 
(a research project on Nordic health effects of whole grain 
consumption, HELGA). Approximately one hundred 
twenty thousand men and women aged 30–64 years expe-
rienced a 64% decreased risk of distal colon cancer (198 
case–control pairs) reported after comparing the highest 
quartiles (>118.6 nM for men and >91.7 nM for women) 
with the lowest (≤35.3 nM for men and <27.5 nM for 
women) of AR plasma concentrations. Investigators sug-
gested that usage of both assays, i.e., plasma ARs detection 
and FFQs of whole grains intake, slightly increases the pre-
cision of the study compared to a measure of the associa-
tion whole grain products intake—cancer risk, using only 
an FFQ as the exposure measurement. This suggestion was 
based on finding no significant relationship between who-
legrain intake and colorectal cancers when an FFQ was 
used as an assay.
Only one observational study [69] was identified and 
included in the comparative analysis between the highest 
and lowest levels of plasma AR metabolite concentrations 
and the risk of prostate cancer that estimated the dose–
response (Table 1). The study analyzed prostate cases from 
the Swedish MDC cohort; the odds ratio among men was 
1.41 (1.10–1.80) of which plasma AR metabolites concen-
trations ranged from 93.0 to 596.2 nM (226 cases) com-
pared to those which plasma AR metabolites concentra-
tion ranging from 34.1 to 55.8 nM (179 cases). A slightly 
higher significant risk was found for low-risk prostate can-
cer (46%); although the positive association between AR 
metabolite concentrations and prostate cancer risk had no 
linear shape. Interestingly, the positive associations of fiber 
and whole grain intake with prostate cancer was found by 
Nimptsch et al. in the Health Professionals Follow-up Study 
(hazard ratios, HR = 1.13; 95% CI = 1.03–1.24, 49,934 
cases) which lacks statistical importance after restriction 
to PSA screening [95]. Investigators also observed non-
significant increased ORs among 647 cases with low risk 
of prostate cancer and 353 cases with high risk, and for 465 
cases with symptomatic prostate cancer. Further, significant 
moderate correlations between AR metabolites and whole 
grain products intake were found. The results from this 
study led investigators to conclude high whole grain intake 
does not reduce risk of prostate cancer.
A case-control study of the Danish postmenopausal 
women aged between 53–60 years including 177 endome-
trial cancer cases and 152 sub-cohort members as a control 
group evaluated concentrations of AR homologues (C17:0–
C25:0) in their plasma [94]. Median AR concentration 
of 78 nM and a lack of statistically important differences 
between cases and controls with regard to the AR concen-
tration in plasma were found. Investigators confirmed that 
rye bread consumption was the primary determinant of AR 
levels and elevation of plasma AR concentrations in non-
fasting blood samples. A group of 360 postmenopausal 
Danish women had the same level of ARs for the joined 
controls and endometrial cancer cases (n = 176) [62].
Cytotoxic activities of alkylresorcinols
Ten in vitro studies [58, 84, 96–103] were identified and 
included in the analysis of natural and synthetic ARs 
for activities that inhibit growth of human cancer cells 
(Table 2). The studies focused on isolation and identifica-
tion of naturally occurring ARs and their synthesis. Two 
studies [58, 96] reported isolation of ARs from wheat bran, 
a synthesis of several dozens of ARs and their evaluation 
for growth inhibitory potential against human colon cancer 
cell lines HCT-116 and HT-29, when treated with various 
concentration of ARs extracted from wheat bran oil [96]. 
Investigators examined a series of ARs having different site 
chain lengths (synthetic including those of short to moder-
ate length side chain: C9:0, C11:0, C13:0, C15:0, C17:0 
[58] and those isolated from wheat bran oil: C17:0–C25:0) 
[96] (see Table 2). The inhibitory effect on the colon cell 
lines growth was reported as an  IC50 (the half maximal 
inhibitory concentration as a measure of the activity of 
AR in inhibiting cancer cell growth). The observed cyto-
toxic effect was dependent on chemical structure of ARs, 
being weaker for the compounds with the longer alkyl site 
chain (C > 17) and dependent on type of colon cancer cells 
HCT-116 or HT-29, with  IC50 values about 15 µM (C13:0 
and C15:0) and approximately 25 µM for compounds 
C:13 and C15:0, respectively [58]. ARs C13:0 and C15:0 
were the most effective as colon cancer cell growth inhibi-
tors, and hydroxyl groups in meta-position at C1 and C3 
on the aromatic ring played an important role in inhibition 
of cancer cell growth. Investigators also found wheat bran 
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oil fractions containing 5-n-alk(en)ylresorcinols exerted the 
strongest inhibitory effect on the proliferation of human 
colon cancer cells [96], however their ability to inhibit 
colon cancer cell lines was lower than synthetic ARs.
In other research, ARs were responsible for the inhibi-
tion of human breast, lung, and central nervous system can-
cer cell growth [97]. The compounds cytotoxicity toward 
cancer have been presented on MCF-7, H-460, and SF-268 
cell lines using five isolated natural ARs. Importantly, the 
isolated ARs exhibited at least an 800% stronger inhibi-
tory effect on the tested cancer cell lines than the com-
monly known cytostatic adriamycin. This study confirmed 
the findings of Zhu et al. [96] that free phenolic hydroxyl 
groups of ARs play important role in anticancer action. 
These findings confirmed also previously published evi-
dence on an inhibitory effect of 14 ARs isolated from 
leaves of a tropical ornamental tree on human breast car-
cinoma, lung carcinoma, and central nervous system car-
cinoma cells [98]. This study observed slightly lower  IC50 
values in the human lung tumor cell line (NCI-H460) com-
pared to the human breast tumor and human central nerv-
ous system cancer cell lines. Investigators suggested the 
comparable values of  IC50, obtained during the cytotoxic 
evaluation of ARs, can attest that the alkyl chain structure 
(straight or cyclic) has no effect on cancer cell inhibition. 
In turn, a study by Liu et al. confirmed in vitro antican-
cer effects of ARs using human prostate adenocarcinoma 
(PC3) cells [99]. Liu et al. isolated seven pure ARs from 
wheat bran and four exhibited strong inhibitory capac-
ity against the growth of PC3 cells; the latter compounds 
C17:0, C19:1, C21:1, and C23:0xo were the minor ARs 
with low yield in the isolation process. In conclusion, Liu 
et al. suggested their results are the first in the literature 
showing the cytotoxicity of ARs with a longer chain than 
C17:0 isolated from wheat bran.
Another study demonstrated the cytotoxic effect of 
5-alkylresorcinol (5-AR) isolated from L. molleoides 
leaves in the human hepatocarcinoma cell lines HepG2 and 
Hep3B [84]. Treatment of both cell lines with 5-AR for 
24 h resulted in induction apoptosis, DNA fragmentation, 
and nuclear condensation. Cell death observed in both cell 
lines tested included AR concentration-dependent where 
 IC50 values found for HepG2 and Hep3B were similar. 
Investigators indicated an important property of 5-AR as of 
an inductor of apoptosis independently on a p53 pathway 
(p53 gene is the most commonly mutated gene in hepato-
cellular cancer). The ability of ARs to inhibit the growth 
of ovarian cancer cells has been reported by Chaturvedula 
et al. [100]. Effects of eight new 5-ARs isolated from leaves 
of Myrsinaceae and two known early ARs on the A2780 
mammalian ovarian cancer cell line were examined. All 
compounds inhibited the growth of the cell line; the inhibi-
tory effect was concentration-dependent, and  IC50 values 
were comparable (17.89–22.92 µM). This finding suggests 
the tested compounds exhibited similar activity toward the 
cancer cells and, according to the researchers, the activity 
depends mainly on the basic skeleton of the 5-ARs.
The ability of ARs to inhibit the growth of prostate, 
colon, and breast cancer cells has been confirmed by Al-
Meklafi et al. [101]. Twelve isolated ARs from an impor-
tant medicinal herb in Malaysia were tested and two ARs 
(structurally very closely related) exhibited the most cyto-
toxic activity against PC-3, HCT-116, and MCF-7 human 
cancer cell lines, and were more active than doxorubicin 
at the  IC50 level. The compounds showed cancer cell-type 
selectivity against PC-3 and HCT-116 cells at concentra-
tion which totally inhibits cell growth and concentration 
which results in cell death of up to 50%. Both compounds 
had a substituted aromatic ring by hydroxyl, methoxyl, and 
acetyl groups and C15:0 alkyl or alkenyl side chain with 
one double bond. According to Al-Meklafi et al., the pres-
ence of the double bond had no effect on the compound 
cytotoxic activity [101].
The studies of Sánchez et al. [97], Chuang and Wu 
[98], and Al-Mekhlafi et al. [101] confirmed the findings 
of Kubo et al. [102] on cytotoxicity of ARs against human 
breast cancer cell lines. Kubo et al. found that ARs and 
their methyl derivatives also exhibited significant cytotox-
icity against human cervical cancer cell lines HeLa. Also, 
a study by Vila-Luna et al. [103] observed the cytotoxic 
effect of two phenolic lipids isolated from roots of B. mac-
rocarpa against several human cancer cell lines includ-
ing cervix (HeLa, SiHa), breast (MCF-7), and prostate 
(DU-145).
Discussion
This review article focuses on a relatively new research area 
because AR benefits have attracted significant interest in 
the last two decades. Evidence from different model stud-
ies show ARs are phenolic lipids abundant in several plant 
families, some bacteria, fungi, algae, and marine sponge, 
mainly as homologues with alkyl chains (C15:0–C25:0), 
though many studies examined derivatives having unsatu-
rated and oxygenated side chains. Dietary ARs are easily 
absorbed by humans and several studies focused on their 
detection in blood plasma, adipose tissue, erythrocytes, and 
their metabolites in urine. Evidence has demonstrated that 
AR content or their metabolites in humans is proportional 
to intake of food products containing whole grains. Thus, 
there is rich evidence on usefulness of plasma and urine 
AR metabolite measurements as biomarkers of whole grain 
food, mainly whole grain wheat and rye consumption [37, 
38, 42, 46, 47, 49, 62, 65, 67]. Studies which analyzed AR 
occurrence, absorption, metabolism, and excretion reported 
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their presence at micromolar concentration in plasma being 
the highest after cereal grain intake and at nanomolar con-
centrations at fasting conditions. All studies confirmed that 
a refining process leaves only trace amounts of ARs in food 
products. Phenolic compounds like ARs can potentially 
affect a number of physiological and pathological pro-
cesses related to metabolism and immune system functions 
[71, 72, 104–111].
Results of model studies indicated that ARs which can 
affect all cellular processes regulated by enzymes, affect 
genotoxicity, suppress an adipocyte lipolisis, have a high 
affinity to erythrocyte membranes, exert indirect anti-
oxidant activity, and have cytotoxic effects on cancer cell 
lines [58, 80, 82, 96–99, 103, 105, 112, 113]. Evidence 
for AR bioactivity in vivo is limited to a few dietary clini-
cal intervention trials which examined the effect of whole 
grains intake [88–90, 114]. The majority of studies high-
light cereal grains as an important source of many other 
bioactive compounds, such as benzoxazinoids, lingnans, 
phenolic acids, tocols, and phytosterols that are known to 
reduce cancer in humans, as recently reviewed [1, 15, 19, 
37, 73, 74, 114–116].
Results based on two case-control studies of lower dis-
tal colon cancer risk with high plasma AR concentrations 
(Table 1) are consistent with a meta-analysis of six pro-
spective and nested case-control studies which reported the 
reduced summary relative risk of colorectal cancer after 
three servings daily of whole grains (RR = 0.83) [5]. Also 
noteworthy, the latest systematic review of 12 studies on 
cancer mortality with 34,797 deaths related to whole grain 
intake (3 studies) or whole grains product intake (9 stud-
ies) found a dose-dependent reduced risk of cancer mortal-
ity (RR = 0.82) [107]. Analysis showed that men with high 
concentrations of AR metabolites in plasma had increased 
prostate cancer risk. In turn, a lack of risk reduction was 
observed in case of endometrial cancer. These findings are 
consistent with evidence from in vitro studies with regard 
to colon cancer but not prostate cancer (Table 2). In vitro 
evidence showed inhibition of colon, breast, lung, and cen-
tral nervous system human cancer cell growth, and the ARs 
cytotoxicity against the prostate adenocarcinoma, hepa-
tocarcinoma, cervix adenocarcinoma, cervix squamous 
carcinoma, and ovarian cancer cell lines. We noticed that 
the chain length of ARs was important for the ARs ability 
to inhibit cancer growth, with shorter chains like C13:0, 
C15:0, and C17:0 appearing to have the highest potency 
of cancer inhibition which is in line with previous find-
ings [105]. Long chain ARs may be absorbed to a lesser 
extent compared to the shorter-chain homologs. The listed 
 IC50 values in Table 2 allow us to suggest high levels of 
ARs appeared to be toxic to cancer cells. These findings 
are consistent with evidence from the model studies which 
reported a lack toxicity of ARs of moderate concentration, 
i.e., of 5–20 µM toward to healthy HepG2 or 3T3-L1 cells 
[42, 107, 113].
The observed differences between findings reported in 
Tables 1 and 2 may be explained by a relative short half-life 
time (~4–5 h) limiting the precision of plasma AR concen-
tration detection, especially in populations in which food 
rich in rye and whole grain components is not consumed 
daily [93], although Landberg et al. reported a high cor-
relation coefficient between plasma AR concentration and 
whole grain wheat and rye intake during a 6-week interven-
tion study [35]. There are several hypothesized mechanisms 
by which ARs can exert inhibition of cancer risk, although 
the mechanisms do not consider the possible interaction 
and synergy between the functional components of a diet, 
like phenolic compounds, fiber, lignans, phytosterols, and 
vitamins, which are reported to exhibit beneficial effects on 
human health including cancer prevention [15, 23, 37, 46]. 
These potential interactions need to be verified with further 
research.
In vitro studies revealed the dose–response cytotoxicity 
of ARs toward many cancer cell lines is due to their strong 
effect on cellular morphology, such as DNA fragmentation 
and nuclear condensation, among others; this action can 
lead to apoptosis [84]. Increase in p53 concentration plays 
a key role in the expression of pro-apoptotic proteins [104]. 
The apoptotic pathway has been confirmed by Barbini 
et al. who observed an induction of apoptosis by 5AR in 
HepG2 and Hep3B cells [84]. The group further under-
lined an important feature of 5-AR for hepatocellular car-
cinoma therapy, i.e., its ability to trigger apoptosis indepen-
dently on p53 or Fas phenotypic profile as they observed in 
Hep3B cells. Also, other research groups have maintained 
the anticancer effects of ARs are explained by enhancing 
apoptosis in genotoxically damaged lymphocytes [72]. 
Some studies provide insight to the ARs structure-depend-
ent relationship finding an important role of free hydroxyl, 
methoxyl, acetyl, or methyl groups on benzene rings for 
observed cytotoxicity [98, 102, 103]. For example, the 
comparable  IC50 values observed in cytotoxicity of 14 pure 
5-ARs by Chuang and Wu [98] were partially explained 
by their antioxidant properties due to scavenging reactive 
oxygen species and/or inhibition of enzymes involved in 
the formation of free radicals under physiological condi-
tions [70]. Alkylresorcinols contain two hydroxyl groups 
placed in meta-position of the phenolic ring, thus they 
have a week direct antioxidant potency. However, under 
alkaline conditions and in the presence of transition metal 
ions, e.g., Cu and Fe, ARs may be converted to trihydroxy-
alkylbenzenes—the compounds of a high antioxidant activ-
ity able to produce superoxide anion radicals and further 
hydrogen peroxide and hydroxyl radicals which can dam-
age DNA, proteins, and lipids [72, 106, 108]. Moreover, the 
next important reported property of ARs that may also be 
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clinically significant is a slower metabolism of these com-
pounds under pathological conditions [67].
Results from this study agree with findings of RCTs 
which demonstrated that participants receiving whole 
grain interventions had reduced fasting concentrations of 
insulin and glucose and reduced levels of total and LDL 
cholesterols, among other potential benefits which can be 
important for reduction of inflammation and certain can-
cers protection, as reviewed by Ye et al. [78]. The evidence 
for the potential role of whole grain food intake for gen-
eral health benefits and mortality prevention [107] recom-
mends increased consumption of whole grain cereal food 
products in most countries [117–119]. According to an 
expert panel report on dietary recommendations [120], at 
least 8 g of whole grains per about 30 g, without a fiber, 
(or at least 51% of total weight as whole grain content) is 
required as a minimum content of whole grains food. The 
recommended quantities of daily whole grain cereal prod-
uct consumption vary considerably between countries 
[7, 120]. For example, at least three servings per day, i.e., 
approximately 48 g per day of whole grain cereals, are rec-
ommended in USA; three to eight servings per day of grain 
products at least one-half of them contain whole grains in 
Canada, at least 50 g per day of coarse grains including 
whole grains in China [120]. In the Scandinavian coun-
tries, at least 75 g of whole grain cereals intake per 10 MJ 
of total energy intake is recommended [40]. Of note, the 
reported dietary whole grains guidelines are much higher 
than their average daily consumption (e.g., 42 g per day in 
Sweden, 36 g per day in Denmark). A study by Piironen 
et al. reported the beneficial influence of whole grains may 
result from the combined action of fiber, vitamins, phenolic 
acid, ARs, micronutrients, and other phytochemicals [121]. 
This suggestion originates from observations that no single 
antioxidant can replace natural phytochemicals in prevent-
ing disease [122]. According to Fardet, there is agreement 
that the protective effect of whole grain cereals results 
from the synergistic action of phytochemicals and micro-
nutrients occurring mainly in the bran and germ fractions 
[7]. To our knowledge, the synergy between phytochemi-
cals present in whole grain cereal products is still not con-
firmed, due to their huge number and numerous biological 
functions. However, the evidence on an association of the 
whole grains consumption and decreased cancer risk is still 
inconclusive.
Limitations of the study
When assessing the relationship between AR concentra-
tions and cancer risk, several methodological issues need to 
be considered. Two of the four analyzed observational stud-
ies used semi-reported food frequency questionnaires to 
assess whole grains intake which is prone to measurement 
errors in evaluation of associations between dietary intake 
and risk of civilization diseases [35, 117, 119, 123]. The 
errors originate from a positive difference between stud-
ies in distinct definition of whole grains, a lack of full food 
composition, large differences of AR concentrations in 
whole grain products, variation in AR concentration with 
time or a dependence of a half-time on the chain length, 
and variability across studies of serving size. Next, not all 
observational studies included a list of potential confound-
ers, such as physical activity, fruits, vegetables or red meat 
intake, ethnicity, and family history of cancer. These varia-
bles, which are lacking in the statistical models, might lead 
to under- or over-estimation of the AR intake/cancer rela-
tionship [4, 6, 112, 124–129]. For example, physical activ-
ity is considered as an important lifestyle component, of 
which the association with colorectal cancer risk has been 
established as conclusive, and with the postmenopausal 
breast cancer as probable [127, 130]. Moreover, a higher 
intake of whole grains is usually reported by individuals of 
healthier lifestyle behaviors, thus all components of life-
style should be included in statistical analyses as important 
confounders. Also, some limitations should be acknowl-
edged when interpreting the findings from in vitro studies. 
The assessment of AR cytotoxicity toward human cancer 
cell lines may be underestimated because phenolic lipid 
content and antioxidant activity of plant extracts largely 
depend on extraction conditions and solvent polarity [56]. 
Due to fermentation processes, the release of ARs in vivo 
may be more effective than under in vitro conditions. Fur-
thermore, bioactivity of isolated or synthesized ARs can 
decline during isolation and storage undergoing oxidation. 
Also, different methods of processing influence AR con-
centration in a food. Plasma concentrations of ARs are also 
influenced by differences in individual absorption and/or 
metabolism rates. Next, the association of ARs with can-
cer may by dependent on embryologic origins, on kinds of 
cancer or subtypes, as seen in observational findings with 
colorectal cancer (Table 1). Moreover, different sensitiv-
ity levels for detection of ARs in biological samples might 
introduce measurement errors which could explain rela-
tively low AR concentrations in plasma. Finally, misclassi-
fication of an outcome when FFQs are used is also probable 
because ARs are considered in the literature as biomarkers 
of whole grain wheat and rye intake, only [92]. A correc-
tion for measurement errors can enhance the reported asso-
ciations and weaken the discrepancy between the findings 
of observational and in vitro studies.
Conclusions
This systematic review demonstrated a renewed interest 
in the beneficial effect of ARs on human health. Evidence 
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indicates that ARs exhibit a variety of bioactivities; they 
can affect many physiological and pathological processes 
related to the immune system, being involved in cell 
signaling and gene regulation. These findings originate 
mainly from model and epidemiological studies where 
assessment of the AR bioactivity in vivo is limited to a 
few dietary clinical intervention trials. ARs characteris-
tic feature is their potential as biomarkers of whole grain 
wheat and rye product consumption. There is evidence 
that individuals with high plasma AR concentrations had 
above 52% reduced risk of distal colon cancer with lin-
ear dependence originating from biomarker concentra-
tion and indirectly from whole grain intake. These find-
ings show that the accuracy of epidemiological studies of 
whole grain intake and cancer risk based on FFQs may 
by increased by detection of AR concentration in plasma. 
In vitro studies show that high-concentration ARs are 
considered highly cytotoxic agents for certain types of 
cancer, reporting inhibition of human colon, breast, lung, 
central nervous, ovarian, cervical, and prostate tumors, 
and hepatocarcinoma cancer cell lines. Furthermore, the 
phenolic ring and alkyl chain are important for inhibition 
of human cancer cells proliferation. This is no common 
consensus or clarity on the toxicity mechanism toward 
cancer cells due to multiple AR targets and the com-
plexity of interrelations between various biochemical 
actions. Observational studies help to evaluate relation-
ships between AR intake and beneficial health effects yet 
cannot be used to establish causality when compared to 
intervention studies. The research literature has generated 
several hypothesized molecular mechanisms of action 
for ARs in the prevention of cancer and their cytotoxic 
activities which include the ability to affect all cellu-
lar processes regulated by enzymes, suppress an adipo-
cyte lipolysis, affect genotoxicity, have a high affinity to 
erythrocyte membranes, and exert indirect antioxidant 
capacity.
Our findings provide further support for public health 
recommendations emphasizing diets rich in whole grains 
as potentially preventive against some types of cancer. 
The updated evidence suggests future studies should 
focus on identification of a fraction from grain cereals 
containing concentrations of ARs exerting the strongest 
cytotoxic effect on cancer cells; this may offer new clues 
to prevent cancer.
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